Anemia as a predictor of outcome in inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at how anemia (low red blood cells) affects the course of inflammatory bowel disease (IBD) in adults. It may help doctors understand if anemia can predict how the disease progresses, which could guide better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with inflammatory bowel disease (ulcerative colitis or Crohn's disease).
- You are being treated or followed at Assiut University Hospitals.
- You have not had a blood transfusion in the last 3 months.
- You must be willing to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fats in your blood and gut lining change in inflammatory bowel disease (IBD). It might help doctors understand IBD better and could lead to better treatments.
This study looks at whether certain blood tests (called inflammatory biomarkers) can help measure how active your inflammatory bowel disease (Crohn's disease or ulcerative colitis) is. It may help doctors better track your condition and guide treatment, without needing invasive procedures.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study looks at how certain natural chemicals called polyamines relate to the activity of inflammatory bowel disease (IBD). It aims to understand if these chemicals can help predict disease progression.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
This trial tests whether an anti-inflammatory diet can help people with inflammatory bowel disease (IBD). Researchers want to see if this diet reduces inflammation and improves symptoms.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.